A novel peptide thrombopoietin mimetic designing and optimization using computational approach

A novel peptide thrombopoietin mimetic designing and optimization using computational approach

Thrombopoietin receptor (TPOR) is a cytokine receptor protein; activation of cell surface TPOR by thrombopoietin (TPO) triggers an intracellular cascade of megakaryocytopoiesis for the formation of platelets. TPO is a glycoprotein hormone which stimulates megakaryocytes formation and maturation to p...

Full description

Bibliographic Details
Main Authors:	Vimal kishor Singh, Neeraj Kumar, Manisha Kalsan, Abhishek Saini, Ramesh Chandra
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-08-01
Series:	Frontiers in Bioengineering and Biotechnology
Subjects:	Thrombopoietin molecular docking molecular dynamics simulation. Thrombopoietin receptor Mimetic Library Designing
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fbioe.2016.00069/full

Similar Items

Serum thrombopoietin and cMpl expression in thrombocytopenia of different etiologies
by: Fabrizio Vianello, et al.
Published: (2014-03-01)

The thrombopoietin receptor: revisiting the master regulator of platelet production
by: Ian S. Hitchcock, et al.
Published: (2021-08-01)

Safety, tolerance, pharmacokinetic and pharmacodynamic properties of thrombopoietin mimetic peptide for injection in Chinese healthy volunteers: a randomized, placebo-controlled, double-blind study
by: Xiao-Yan Sheng, et al.
Published: (2022-11-01)

Chronic liver disease, thrombocytopenia and procedural bleeding risk; are novel thrombopoietin mimetics the solution?
by: Sven R. Olson, et al.
Published: (2019-08-01)

Use of thrombopoietin receptor agonists in childhood immune thrombocytopenia
by: Angelica Maria Garzon, et al.
Published: (2015-08-01)

Trombinol, a bioactive fraction of Psidium guajava, stimulates thrombopoietin expression in HepG2 cells
by: Guntur Berlian, et al.
Published: (2017-05-01)

Review article: THE ROLE OF ELTROMBOPAG AND ROMIPLOSTIM AS THE THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) IN TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): WHAT IS TPO-RA, WHEN TPO-RA IS USED AND HOW TO TAKE TPO-RA?
by: Jefri Pratama Susanto
Published: (2016-11-01)

Plasma thrombopoietin levels as additional tool in clinical management of thrombocytopenic neonates
by: Leendert Porcelijn, et al.
Published: (2020-01-01)

Hepatitis C virus-associated thrombocytopenia is not related to serum thrombopoietin levels
by: Afifi Ola, et al.
Published: (2007-01-01)

The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis
by: Ingrid Lindquist, et al.
Published: (2022-01-01)

The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN
by: Jerry L. Spivak, et al.
Published: (2021-03-01)

Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia
by: Olga S. Levchenkova, et al.
Published: (2023-03-01)

Association between megakaryocyte abnormalities on bone marrow smear and response to thrombopoietin receptor agonists in adult patients with primary immune thrombocytopenia
by: Ondine Walter, et al.
Published: (2022-11-01)

Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome
by: Mengying Zhang, et al.
Published: (2023-09-01)

Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently
by: Mohamed A. Yassin, et al.
Published: (2023-12-01)

An Analysis of the Serum Metabolomic Profile for the Radiomitigative Effect of the Thrombopoietin Receptor Agonist Romiplostim in Lethally Whole-Body-Irradiated Mice
by: Yoshiaki Sato, et al.
Published: (2022-02-01)

A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
by: Gurleen Oberoi, et al.
Published: (2022-01-01)

Feasibility of romiplostim discontinuation in adult thrombopoietin-receptor agonist responsive patients with primary immune thrombocytopenia: an observational retrospective report in real life clinical practice
by: Monica Carpenedo, et al.
Published: (2015-02-01)

Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity
by: Abhay Singh, et al.
Published: (2015-01-01)

Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation
by: Longfei Gao, et al.
Published: (2021-08-01)

Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists
by: Lamya Garabet, et al.
Published: (2020-04-01)

Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP)
by: Sif Gudbrandsdottir, et al.
Published: (2017-07-01)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
by: Kensaku Nakai, et al.
Published: (2022-02-01)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
by: Alessandro Pecci, et al.
Published: (2018-01-01)

Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study
by: Yu Liu, et al.
Published: (2020-09-01)

A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
by: Heng Mei, et al.
Published: (2021-02-01)

Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice
by: V V PTUSHKIN, et al.
Published: (2018-07-01)

Role of thrombopoietin stimulating agents(Eltrombopag and Romiplostim) in immune thrombocytopenia secondary to SLE
by: Toro Vélez, Esteban, et al.
Published: (2021-07-01)

Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension
by: Hanny Al‐Samkari, et al.
Published: (2022-02-01)

Developmental differences between newborn and adult mice in response to romiplostim
by: Katherine A. Sparger, et al.
Published: (2018-05-01)

Development of an Automated Chemiluminescent Enzyme Immunoassay for Measuring Thrombopoietin in Human Plasma
by: Yukihiro Nishikawa, et al.
Published: (2022-01-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Knowledge map of thrombopoietin receptor agonists: A bibliometric analysis
by: Rong Hu, et al.
Published: (2024-01-01)

Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
by: Jiwon Shin, et al.
Published: (2023-05-01)

The role of thrombopoietin receptor agonists in the management of adult primary immune thrombocytopenia: A single centre experience
by: Virijević Marijana, et al.
Published: (2022-01-01)

Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study
by: Hongnan Mo, et al.
Published: (2021-09-01)

Study of thrombopoietin levels in some Egyptian patients with chronic liver diseases secondary to the hepatitis C virus
by: Enayat O. Ezzat, et al.
Published: (2012-01-01)

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
by: Tsykunova G, et al.
Published: (2022-03-01)

A novel recombinant human thrombopoietin for treating prolonged isolated thrombocytopenia after allogeneic stem cell transplantation
by: Yu-Qian Sun, et al.
Published: (2019-11-01)

Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers
by: Jean-Philippe Defour, et al.
Published: (2023-06-01)